P hosphatidylinositide 3-kinases (PI3Ks) are central integrators of signal transduction, coupling cell-surface receptors to intracellular signaling pathways, such as the Akt and mTOR pathways, to regulate growth and metabolism 1 . Key activators of the PI3K pathway in T cells, such as the IL-2 receptor, play a critical role in enabling cells to exit quiescence and progress through the cell cycle 2, 3 . Among the primary targets of the PI3K-Akt pathway in T cells are transcription factors from the Foxo family. Both Foxo1 and Foxo3 have largely redundant but complex roles in maintaining T cell quiescence and controlling the response to growth factors and inflammatory stress 4, 5 . In quiescent cells, Foxos are restricted to the nucleus and maintain transcriptional activity; cell activation induces the Akt-mediated phosphorylation of three evolutionarily conserved serine and threonine residues on Foxos, thus leading to Foxo exclusion from the nucleus and hence termination of transcriptional activity. Loss of Foxo1 in T cells results in the development of a mild lymphoproliferative and autoimmune phenotype 6, 7 . This phenotype is distinct from that in mice with regulatory T cell (T reg )-specific deletion of Foxo1, in which lethal inflammation is observed after loss of dominant tolerance without compromised conventional T cell function 8 . The kinase mTOR coordinates metabolic pathways that dictate T cell fate, although the mechanisms underlying this role have not been completely described. T reg cells from mice with a T reg -specific deletion of Raptor, an essential component for mTOR complex 1 activity, are deficient in cholesterol and lipid metabolism, and consequently these cells exhibit proliferation and maintenance defects 9 . In mice with Raptor deletion in all T cells, glycolytic, lipid-synthesis and oxidative-phosphorylation programs are severely impaired, thus preventing T cell exit from quiescence 10 . These differences reflect altered use of metabolism in T cells of different lineages and indicate that mTOR is central in driving each of these programs.
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How the activity of Foxos intersects with these signaling pathways is incompletely understood, as is the role that termination of Foxo1 activity plays in coordinating the T cell response to stimulation. To understand how control of Foxo1 transcriptional activity regulates T cell function and homeostasis, we used mice that conditionally express a constitutively active Foxo1 protein (Foxo1 AAA ). We show that inactivation of Foxo1 is required to maintain CD4 T cell and T reg cell homeostasis in vivo, because T cell-specific Foxo1 AAA expression provokes severe autoimmunity in mice, which is preventable with wild-type cells. Using CD4 T cells inducibly expressing Foxo1 AAA , we show that maintaining Foxo1 activity leads to a decrease in cell size and cholesterol accumulation, and an inability to sustain signaling by the nutrient sensor mTORC1, but paradoxically also increases cell-division rates. Further analysis indicated that this phenotype was caused by loss of expression of the IL-2R β -chain and STAT5-dependent upregulation of the transcription factor Myc. Together, these data show that termination of Foxo1 activity is required to coordinate cell growth with cell proliferation, a critical process needed to maintain both homeostasis and responses to stimulation. ) developed a severely moribund state as early as 4 weeks of age, showing stunted growth and ulcerative dermatitis ( Fig. 1a) associated with a prominent mononuclear cell infiltrate in the liver and lungs, splenomegaly and lymphadenopathy ( Fig. 1a and Supplementary Fig. 1a,b) . In the transgenic mice, compared with wild-type mice, despite increased cellularity of the spleen and lymph nodes, a selective decrease in both the frequency and 
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+ T reg cells from the blood 10 weeks post-transfer (right; n = 5 mice). For b, c and e-h, quantification involved a two-tailed Student's t test with no adjustments made for multiple comparisons; center value, mean; error bars, s.d.; **P < 0.005; ***P < 0.0005; ****P < 0.0001; NS, not significant. hi CD44 lo (quiescent) cells from mixed chimeras (i). Genes represented in blue and red have a log 2 fold change of < -1, and > 1, respectively, and an adjusted P value < 0.05. One data point in h (Ctse; log 2 fold change, -5.19; -log 10 adjusted P value, 121.5) is outside the axis limits to depict the dataset more clearly. j,k, Gene-set enrichment analysis showing underrepresentation of genes involved in Myc signaling and ribosome biogenesis (j) and cholesterol biosynthesis (k), in activated versus quiescent AAA CD4 T cells, as in i above. The heat map on the right (in k) displays the row minimum and maximum values of expression for the entire reactome cholesterol-biosynthesis annotated gene set. The log 10 Benjamini-Hochberg-adjusted P values were used, corrected for the direction of fold change, to rank genes. For any adjusted P-value cutoff, Benjamini-Hochberg correction was used. FDR, false discovery rate.
number of CD4 T cells was observed, but there were no significant differences in CD8 T cell numbers (Fig. 1b) . T reg cell frequencies were severely decreased, and within the remaining T reg cell population, CD25 expression was downregulated despite high expression of the suppressive molecules ICOS and CTLA-4 ( Fig. 1c and Supplementary Fig. 1c-e) .
Both CD4 and CD8 T cells exhibited an activated phenotype with elevated expression of CD44 and Ki-67, and produced high amounts of the cytokine IFN-γ and the serine protease granzyme B, respectively, directly ex vivo ( Supplementary Fig. 1f -h and data not shown). An expanded and activated B cell population developed concomitantly with an elevated frequency of Tfh cells and of IL-4-producing cells within the remaining CD4 population ( Supplementary  Fig. 2a-e) . We observed elevated serum IgM, IgG and particularly IgG1 antibodies, as well as IgM and IgG autoantibodies reactive toward HEp-2 cells ( Supplementary Fig. 2f-j) . This result was associated with renal IgG deposition resembling lupus nephritis, as well as anemia and hypoglycemia ( Supplementary Fig. 2k-m) . CellTrace Violet CellTrace Violet Cre-ERT2 Foxo1 AAA/+ mice for four to five consecutive days starting from day 0, and spleens and lymph nodes were harvested at days 7 or 8. a, CD4
+ gate of whole splenocytes (n = 5 mice). No sorting was performed on cells harvested from tamoxifen-treated mice before plating. b,c, Harvested lymphocytes were sorted to obtain both GFP -and GFP + naïve cells (CD4
). For isolated cultures (isocultures; b, n = 8), each population was plated in separate wells for the duration of the experiment in vitro, and cocultures (c, n = 6) combined GFP -and GFP + populations at a 5:1 ratio. d, Flow cytometric analysis of 4-d cultures, activated as in b, with gating on all generations to compare differences in cell size, as measured by forward-scatter area (FSA), and quantification of FSA, depicting GFP + mean FSA as a percentage of mean FSA in control GFP -cells for each given day (day 0, n = 6; day 1, n = 4; day 2, n = 6; days 3 and 4, n = 10). e, Persistence of AAA + cells in vivo after tamoxifen treatment. Tamoxifen was administered to both CD4
Cre-ERT2 Foxo1 AAA/+ (iAAA; n = 3 mice) and CD4 Cre-ERT2 Rosa26 YFP/+ (iYFP; n = 6 mice) control mice for five consecutive days, and the percentage of GFP + cells (from iAAA mice) and YFP + cells (from iYFP mice) was followed in the blood for 11 weeks. All mice were 20-22 weeks old before tamoxifen administration to minimize dilution of induced populations via strong thymic output. f, After administration of tamoxifen to mice (8-12 weeks old) as in e, bromodeoxyuridine (BrdU) was injected every 12 h for three consecutive days, beginning 2 weeks post-tamoxifen. Spleens were harvested, and CD4
+

BrdU
+ cells (shown in histograms) were analyzed for cell size according to FSA (n = 6). For all graphs, quantification involved a two-tailed Student's t test with no adjustments made for multiple comparisons; center value, mean, error bars, s.d. *P < 0.05; **P < 0.005; ***P < 0.0005; ****P < 0.0001.
To determine whether the observed alterations in CD4 T cells and T reg cells were cell intrinsic with respect to Foxo1 AAA expression, we generated bone marrow chimeras. Rag1 -/-recipient mice receiving bone marrow from Foxo1 AAA donors (single chimeras) reproduced the cellular phenotype of nonchimeric CD4
Cre Foxo1 AAA/+ mice (showing a paucity of CD4 T cells and T reg cells, and a high proportion of activated T cells), with immune cell infiltrates in visceral organs and skin, and six of eight mice exhibited a failure to thrive by 16 weeks post-transfer (Fig. 1d) AAA hematopoietic stem cells contributed equally to the reconstituted CD8 T cell compartment (Fig. 1f,g ). Together, these results demonstrate that inactivation of Foxo1 is required , glutamine consumption (c) and glutamate production (d) from isocultures on days 2 (n = 4) and 3 (n = 3). e-k, Quantification of ECAR (e), glycolytic capacity (f,g), OCR (i) and spare respiratory capacity (j,k) under basal conditions and in response to oligomycin (oligo), fluoro-carbonyl cyanide phenylhydrazone (FCCP), rotenone (Rot)/antimycin A (AntA), glucose and 2-deoxyglucose (2-DG) on day 3 of isocultures. Data are representative of two independent experiments with similar results. ECAR/OCR ratio (h) was determined with the glycolytic stress test, for which ECAR traces alone are shown as in e. For all graphs, quantification involved a two-tailed Student's t test with no adjustments made for multiple comparisons; center value, mean; error bars, s.d. *P < 0.05; **P < 0.005; ***P < 0.0005; ****P < 0.0001. l, Immunoblot analysis of isocultures stimulated with plate-bound anti-CD3 and soluble anti-CD28. Data are representative of three independent experiments with similar results. m, Immunoblot analysis of iso-and cocultures stimulated as in l. Data are representative of two independent sorting experiments with similar results. After sorting, a proportion of GFP -and GFP + cells were immediately lysed (Day 0). After 3 d in culture, isolated cultures were lysed and probed, and cocultures were sorted once again for GFP and GFP + populations, lysed and probed. β -actin was used as a loading control.
for cell-intrinsic maintenance of both conventional CD4 + T cells and T reg cells.
Foxo1 activity suppresses the coordination of CD4 T cell growth and proliferative pathways. The absence of autoimmunity in the mixed bone marrow chimeras allowed us to determine how maintained Foxo1 activity affected T cell transcriptional profiles without the potential bias of background inflammation ( Supplementary Fig. 3a,b) . We found few notable differences in gene expression between wild-type and Foxo1 AAA -expressing CD4 peripheral T cells, thus reinforcing our observation that Foxo1 AAA expression does not intrinsically affect CD4 T cell quiescence (Fig.  1h) . To understand how dysregulation of Foxo1 affected activated CD4 T cells in vivo, we took advantage of the observation that the absence of a functional T reg cell population in single chimeric recipients of Foxo1 AAA bone marrow led to spontaneous CD4 T cell activation, and we therefore compared these cells and Foxo1 AAA -expressing CD4 T cells from mixed bone marrow chimeras (Fig.  1i) . We observed that the Foxo1 AAA CD4 T cells from single-chimeric mice exhibited hallmarks of T cell activation and upregulated expression of multiple chemokine and cytokine receptors and ligands ( Supplementary Fig. 3c -e). Gene-set enrichment analysis of differentially expressed genes in Foxo1 AAA CD4 T cells from single-chimeric mice indicated that additional pathways, including ribosome biogenesis and the Myc transcription factor, which are largely interdependent, as well as cholesterol biosynthesis, were unexpectedly downregulated as compared with levels in the quiescent Foxo1 AAA population (Fig. 1j,k) . The unexpected finding of downregulation of Myc, cholesterol biosynthesis and ribosome biogenesis pathways in activated versus resting Foxo1 AAA CD4 T cells led us to ask how this result might compare with those in activated versus resting wild-type CD4 T cells. To answer this question, we made use of public data comparing conventional CD4 T cells from wild-type mice and conventional CD4 T cells from Scurfy mice 11 . This comparator group seemed particularly apt, given that conventional CD4 T cell activation arises in conjunction with defects in the T reg cell compartment in both Scurfy mice and our single-chimeric mice. Gene ontology analysis revealed that genes involved in cell-cycle progression and cell division, and in cytokine signaling, were upregulated in conventional CD4 T cells from Scurfy mice and were not comparably induced in Foxo1 AAA CD4 T cells from single-chimeric mice ( Supplementary  Fig. 4a,b) . In addition, ribosome-biogenesis and cholesterol-biosynthesis pathways were not comparably downregulated in effector T cells from Scurfy mice, thus indicating that dysregulation of these pathways was not merely a consequence of the loss of a regulatory population ( Supplementary Fig. 4c,d ). Given the importance of Foxo proteins in controlling metabolism [12] [13] [14] , we reasoned that these differences might be a consequence of failed metabolic checkpoints coupled to cell-cycle progression. Indeed, we found that many genes e, Isocultures were labeled with CellTrace Violet and stimulated as in a, with the additional condition that on day 2, 30 ng/ml anti-IL-2 blocking antibody (diluted in medium) or the equivalent volume of medium alone, was added to isolated cultures, followed by 80 ng/ml anti-IL-2 on day 3. Cells were stained for 7AAD and analyzed by flow cytometry on day 4 (n = 4 cultures). Quantification for the proportion of 7AAD + cells on day 4 is shown on the right. For all graphs, quantification involved a two-tailed Student's t test with no adjustments made for multiple comparisons; center value, mean; error bars, s.d. *P < 0.05; **P < 0.005; ***P < 0.0005; ****P < 0.0001; NS, not significant. involved in metabolic pathways previously shown to be upregulated in wild-type T cells after activation were suppressed in activated Foxo1 AAA CD4 T cells (compared with quiescent AAA CD4 T cells; Supplementary Fig. 5 ) 15, 16 . To further explore the consequences of Foxo1 AAA expression in CD4 T cells in a noninflammatory environment, we bred Foxo1 AAA mice to CD4 Cre-ERT2 mice to allow for acute induction of Foxo1 AAA in peripheral CD4 T cells after administration of tamoxifen. Mice were given tamoxifen for 5 d, and organs were harvested on day 8. In cultures of whole splenocytes stimulated with anti-CD3 plus anti-CD28 (anti-CD3/28), we observed less proliferation in Foxo1 AAA -expressing cells (GFP + ) than in cells from the same animal in which Foxo1 AAA was not induced by tamoxifen (GFP -) (Fig. 2a ). This proliferation defect was reversed, and in fact a hyperproliferative phenotype was revealed, when GFP + and GFP -cells were sorted before activation and maintained separately as isolated cultures (isocultures; Fig. 2b ). A hypoproliferative phenotype was once again observed when GFP + and GFP -cells were recombined and cocultured after sorting ( Despite the hyperproliferative phenotype demonstrated in isocultures, GFP + cells had a greatly diminished cell size (Fig. 2d ). This decrease was seen throughout 'generations' (i.e., cell divisions), thus indicating that this observation was not a consequence of a greater proportion of cells having gone through a higher number of divisions. This decrease in cell size was also seen in cocultures (data not shown), and thus this trait was not linked to proliferative capacity. In vivo, when the proportion of GFP + cells compared with that of YFP + cells from control CD4 Cre-ERT2 Rosa26 YFP/+ mice was measured in the blood over time, we observed decreased maintenance of Foxo1 AAA -expressing cells after tamoxifen treatment (Fig. 2e) , and this observation was also accompanied by decreased cell size among dividing cells (Fig. 2f) . These findings indicate that the competitive disadvantage observed for Foxo1 AAA -expressing cells in vitro is present in vivo as well.
Foxo1 activity limits cell metabolism via impaired Myc and IL-2 signaling. During the first 2 d of activation (i.e., before proliferative differences were observed), standard outputs of metabolic activation, including consumption of glucose and glutamine, and production of lactate and glutamate, were not affected by Foxo1 AAA expression ( Fig. 3a-d and Supplementary Fig. 6a ). However, these outputs were significantly decreased by day 3 (Fig. 3a-d) , thus prompting us to examine T cell metabolism through bioenergetic analysis at that time point. As assessed by the extracellular acidification rate (ECAR) and oxygen consumption rate (OCR), we found that both basal and maximal glycolytic and oxidative rates were greatly diminished at day 3, thus indicating that cell metabolism + populations (f, n = 3; g, n = 6; h, n = 4). For all graphs, quantification involved a two-tailed Student's t test with no adjustments made for multiple comparisons; center value, mean; error bars, s.d. *P < 0.05; **P < 0.005; ***P < 0.0005; NS, not significant.
is constrained by constitutive Foxo1 activity (Fig. 3e-k) . We measured expression of key metabolic regulators and found that although expression of the transcription factor Hif-1α was higher than that in wild type, in agreement with a high ECAR/OCR ratio, the normal pattern of Myc expression was disrupted (Fig. 3l) . Specifically, Myc induction at 24 h was not affected, but at later time points, Myc expression was lower in Foxo1 AAA -expressing cells ( Supplementary Fig. 6b ). This result was independent of proliferative state, because it was observed in both the iso-and cocultures and was associated with low levels of Myc mRNA ( Fig. 3m and Supplementary Fig. 6c,d ).
IL-2 signals contribute to Myc upregulation after T cell activation 17, 18 . Furthermore, sustained IL-2 signals are critical to maintain Myc expression postactivation, whereas blockade of IL-2 signals with inhibitors of JAK kinases, or by IL-2 withdrawal, results in a rapid decrease in Myc expression. Although we found no alterations in IL-2 mRNA or protein production, or in the expression of the α or γ c chain of IL-2R (CD25 and CD132, respectively; data not shown), we observed that expression of the IL-2Rβ chain (CD122) was lower at baseline than that in wild-type cells, and it became progressively and selectively downregulated after activation (Fig. 4a-c) . However, we could not attribute the lower expression of CD122 to the failure to sustain Myc, because CD122 expression was lower than that in wild type at day 0 (i.e., before the normal induction of Myc) and became progressively lower even before the defect in Myc expression was seen. Furthermore, we observed a decrease in neither CD122 transcripts, as measured by qPCR, nor total protein levels, as assessed by both immunoblotting and intracellular staining followed by flow cytometry ( Supplementary Fig. 6e-g ), thus indicating that only surface expression was decreased.
The diminished expression of CD122 correlated with decreased activation of the transcription factor STAT5 (phosphorylated (p-) STAT5) after stimulation (Fig. 4d) . In agreement with this result, stimulation of cells with additional IL-2 during the first 24 h of activation did not restore p-STAT5 in GFP + cells (data not shown). Furthermore, GFP + cells were selectively sensitive to inhibition of growth signals by anti-IL-2, as indicated by enhanced cell death, thus suggesting that the observed competitive disadvantage in the coculture system might be conferred by compromised IL-2 signaling (Fig. 4e) .
In activated T cells, increased glycolysis and mitochondrial metabolism provide precursors for biosynthetic pathways, thereby linking Myc-dependent catabolism with anabolic generation of complex molecules 10, 16, 19, 20 . Given the observed defect in Successful formation was defined by the appearance of a highly dense 2C11 area excluding ICAM-1 at the site of SLB interaction (wild type, n = 6 cultures; AAA, n = 6; AAA + cholesterol (chol.), n = 3). c-e, Quantification of TCR and LFA-1 recruitment, as determined by integrated density (int. dens.) of 2C11 and ICAM-1, respectively. IRM was used to determine T cell spreading, and area was used as a mask for quantification of integrated fluorescence density. K denotes thousands. f, Cellular levels of cholesterol, determined by Filipin staining. Graphs indicate percentage or mean ± s.e.m. One-way analysis of variance was performed on all datasets and indicated P < 0.0001 for each. P values were determined with the Mann-Whitney two-tailed t test to directly compare two individual groups. ****P < 0.0001; NS, not significant.
cell growth, we examined pathways that contribute to biomass accumulation. In agreement with our transcriptome analysis indicating dysregulation of genes involved in cellular cholesterol metabolism (Fig. 1j,k) , we observed a notable decrease in the free-cholesterol levels of Foxo1 AAA -expressing cells compared with wild-type T cells, as assessed by Filipin staining. This result was observed as early as 24 h postactivation and increased by 48 h in culture (Fig. 5a,b) . We measured transcript levels of genes involved in cholesterol biosynthesis during initial stages of T cell activation, including those that were significantly altered on the basis of gene expression profiling of chimeric mice, and we found no observable defects, thus suggesting that Foxo1 activity does not directly regulate this gene program and that decreased cholesterol accumulation is linked to the observed defects in catabolic pathways (data not shown). Microscopy images showing GFP -and GFP + cells with a markedly different degree of Filipin staining further suggested that the decrease in cellular cholesterol was not merely due to decreased biomass (Fig. 5b) .
To determine the role of decreased Myc and IL-2 signaling in the suppression of both cholesterol accumulation and cell size in Foxo1 AAA -expressing cells, we used a retroviral system to restore these pathways.
Delivery of a constitutively active STAT5b construct increased expression of Myc, normalized the cholesterol deficit in GFP + cells and further increased the cholesterol content of GFP -cells (Fig. 5c-e ). This result not only confirms that IL-2 signals upregulate Myc but also indicates that IL-2 regulates cellular cholesterol levels. Furthermore, rather than occurring via a direct translational or transcriptional effect, Foxo1-mediated repression of STAT5 activity accounts for loss of Myc, and CD122 is a key intermediary between Foxo1 and Myc. In contrast, retroviral overexpression of Myc was sufficient to rescue the defect in cell size in Foxo1 AAA -expressing cells but had no effect on cholesterol accumulation. Together, these results indicate that Foxo1 activity uncouples cholesterol accumulation and overall biomass accumulation via a Myc-independent mechanism (Fig. 5f-h ).
Cholesterol-dependent immunological synapse formation is controlled by Foxo1 signals. Cholesterol is crucial for the formation of an immunological synapse 21, 22 . To examine how dysregulation of metabolism after activation of Foxo1 AAA -expressing cells affects their ability to form an immunological synapse, we used total internal reflection fluorescence microscopy on cells that were preactivated for 3 d and then allowed to interact with supported lipid bilayer . For all graphs, quantification involved a two-tailed Student's t test with no adjustments made for multiple comparisons; center value, mean; error bars, s.d. *P < 0.05; **P < 0.005; ***P < 0.0005; NS, not significant.
(SLB)-containing fluorescent ICAM-1 and CD80, and anti-CD3e stimulatory antibody 2C11. We found that Foxo1 AAA -expressing cells did not develop a mature synapse with a central supramolecular activation cluster (cSMAC), as defined by the appearance of a highly dense 2C11 area excluding ICAM-1 at the site of the SLB interaction ( Fig. 6a-e) . Additionally, we visualized the SLB-bound T cell surface area by using interference reflection microscopy, and we found that this area was greatly reduced in Foxo1 AAA -expressing cells, in agreement with their diminished cholesterol content (Fig. 6a,f) . To determine whether these features were a direct consequence of diminished cholesterol content, we supplemented cells with watersoluble cholesterol immediately before imaging. This supplementation restored synapse formation, recruitment of T cell receptor (TCR) and the integrin LFA-1, and T cell spreading to levels equal to or above those seen in control cells (Fig. 6a-f ). This result suggests that downstream signaling effects may potentially emanate from a defect in cholesterol-dependent immunological synapse formation.
Maintained Foxo1 activity dysregulates Akt and impairs lysosomal biogenesis and mTORC1 signaling. Because cSMAC formation is associated with termination of TCR signaling by shedding of TCR molecules in extracellular vesicles 23 , and given the role of Foxos in T cell metabolism, the defective cSMAC formation in Foxo1 AAA T cells prompted us to investigate TCR-coupled Akt activation. In contrast to reduced cellular metabolism, we observed enhanced activation (i.e., phosphorylation) of Akt (Fig. 7a,b) . Similarly to Akt, Sgk1 has been shown to phosphorylate the three conserved serine/threonine residues on Foxos that also are targeted by Akt 24 . We noted an increase in phosphorylation of the Sgk1 target Ndrg1, thus indicating that Sgk1 activity was also elevated and suggesting that Foxos participate in a self-regulatory feedback mechanism to limit their activity (Fig. 7a) . However, this increase in p-Akt did not translate into an increase in mTORC1 activity (as assessed by p-mTOR, p-S6 and p-4E-BP1 levels; Fig. 7a ), nor was it reflected by increased mTORC2 activity (as assessed by p-PKCα levels) (Supplementary Fig. 7a ). Instead we observed decreases in both mTORC1 and mTORC2 activity, in agreement with cell growth defects and diminished Myc protein levels. We explored the possibility that decreased mTORC1 activity, or Foxo1 activity itself, might result in a hyperautophagic state potentially contributing to cell-growth defects. However, we found that regulation of autophagy, as assessed by LC3-I/II immunoblotting, remained intact (data not shown).
We similarly observed elevated Akt phosphorylated on Thr308 (Supplementary Fig. 7b ). This event is mediated by Pdk1 (ref. 1 ); however, Pdk1 activity was not elevated, nor did we observe an increase in expression of the mTORC2 component Rictor to account for increased Ser473 phosphorylation ( Supplementary  Fig. 7c and data not shown) . Additionally, we tested a role for the kinase DNA-PK, which has previously been shown to target Akt on Ser473 (ref. 25 ) and found that whereas an inhibitor of DNA-PK reduced Ser473 phosphorylation in wild-type cells, thus indicating that this kinase does contribute to activation of Akt after T cell activation, Foxo1 AAA T cells maintained dramatically high Ser473 phosphorylation, thus indicating that DNA-PK activity does not appear to be dysregulated or critical for the observed hyperactivation of Akt (Supplementary Fig. 7d ). However, we did observe that, unlike wild-type cells, Foxo1 AAA -expressing cells maintained surface CD3 levels after activation and did not upregulate PD-1 expression, thus potentially accounting for increased signaling through the T cell receptor 26 , failure to recruit phosphatases to TCR signaling complexes or an inability to terminate TCR signaling via vesicle release 27 ( Supplementary Fig. 7e,f) . Additionally, we observed a dramatic decrease in the expression of the tumor suppressor PTEN, which plays a dominant role in negatively regulating PI3K signals (Supplementary Fig. 7g ). Together, these data suggest that multiple mechanisms are likely to increase activation of Akt.
To further probe the role of Akt activation downstream of Foxo1 in the cellular phenotype of AAA mice, we bred CD4 Cre Foxo1 AAA mice to Rictor fl/fl mice. We found that loss of Rictor did not reverse the abnormal lymphoid composition of CD4 Cre Foxo1 AAA mice (Fig.  7c,d ), nor did it prevent the increase in Akt activation in Foxo1 AAA CD4 T cells after stimulation (Fig. 7e) . These findings suggest that mTORC2 is not required for activation of Akt in the context of constitutive Foxo1 activity. mTORC1 activation depends on both growth factors (via Akt) and nutrients (in particular, amino acids), and takes place specifically at the lysosome 15, 28 . Although activation of Akt is necessary for mTORC1 activity in most contexts, it is not sufficient, and lysosomal cholesterol has recently been identified as a key 'nutrient' required for mTORC1 recruitment and activation at the lysosomal surface 29 . Given the decrease in membrane cholesterol levels, we reasoned that lysosomal content might also be decreased, because pathways that control accumulation of both lysosomes and cholesterol overlap in their regulation and could both potentially alter activation of mTORC1 (refs. 29, 30 ). Indeed, we observed decreased maturation of the lysosomalmembrane protein Lamp-1 in Foxo1 AAA -expressing cells, as assessed by detection of its glycosylated form by SDS-PAGE, thus suggesting a defect in cholesterol-dependent lysosomal biogenesis (Fig. 8a) . This finding led us to reexamine the loss of CD122 surface expression that we previously could not account for. We hypothesized that shuttling and/or recycling of CD122 via the endocytic or lysosomal pathway might be defective. By blocking endocytosis with Dynasore (a chemical inhibitor of dynamin-and clathrin-mediated endocytosis), we restored surface CD122 levels in a dose-dependent manner (Fig. 8b) . This result confirms that a defect in this pathway accounts for decreased surface expression of CD122.
Further evidence of abnormal mTOR activity was obtained through confocal microscopy. In the absence of growth factors and nutrients, wild-type cells showed diffuse mTOR staining without Lamp-1 colocalization ( Supplementary Fig. 8 ). When nutrients were supplemented to the medium, mTOR staining became punctate and colocalized with the lysosome. In contrast, in Foxo1 AAA -expressing cells, we observed constitutive colocalization of mTOR with Lamp-1, but most notably, a greatly diminished Lamp-1 signal. Importantly, this phenotype persisted even when Foxo1 AAA -expressing cells were activated (Fig. 8c) . These data suggest that Foxo1 enforces physiological constraints on cholesterol and lysosomal content such that mTORC1 activity cannot be sustained, despite elevated levels of Akt activation. Thus, the effect of maintaining Foxo1 activity results in a benefit/cost ratio that may support a proliferative advantage under specific settings but ultimately compromises metabolic fitness and the ability of these cells to persist, either under homeostatic conditions or in a competitive environment.
Discussion
Previous work has linked silencing of Foxo1 to enabling Mycdependent metabolic activity and growth in endothelial cells 14 . Our studies confirm and extend this concept yet also indicate a number of crucial new findings. In contrast to the role of Foxo1 in promoting endothelial cell quiescence, we did not observe a coordinated decrease in the proliferative and metabolic activities of CD4 T cells by maintaining Foxo1 activity. Instead, we found that inactivation of Foxo1 is, in fact, needed to match proliferative and metabolic rates.
In response to growth-factor withdrawal, CD4 T cells reduce cell surface area to minimize energy expenditure while conserving biomass 31 . Under such conditions of nutrient stress, regulation of cell size can be thought of as a means to promote survival. Our data indicate a key role of Foxo1 in the process. In the context of maintained Foxo1 activity, we found a cell-intrinsic decrease in cell size and cholesterol content independent of nutrient availability and increased viability after activation despite diminished growth-factor signals. Moreover, these events are partly dependent on repression of Myc.
In addition to the diminished expression of Myc seen with continued Foxo1 activity, we observed decreases in mTORC1 and mTORC2 signaling. mTORC1 is activated and sustained by both glutaminolysis 32 and glycolysis 33 , pathways that are driven by Myc in activated T cells 16, 34 ; moreover, mTORC1 activity itself can regulate Myc translation 35 . Our data show that although increasing Myc expression via retroviral delivery rescues cell-growth defects, only restoration of signals downstream of IL-2 enables the accumulation of cholesterol that under normal circumstances supports cell growth. Thus, Foxo1 controls both Myc-dependent and Myc-independent growth pathways that diverge at the level of IL-2 signaling.
A specific defect in cholesterol synthesis has been demonstrated in T reg cells that lack mTORC1 activity, owing to a loss of Raptor 9 . Although mTORC1 signaling is diminished by Foxo1 activity, our data suggest that this effect is, at least in part, a consequence of a cholesterol deficit. Cholesterol is a key component of mTORC1 activation 29 , an event that requires mTORC1 localization to the surface of the lysosome 32 . In cells expressing Foxo1 AAA , we observed that lysosomal content decreased, a result consistent with diminished cholesterol levels 29, 30 . Thus, although decreased mTORC1 activity might contribute to anabolic defects, this process is likely to be a complex regulatory loop, not a simple 'linear' pathway. We also found that the immunological synapse formation of previously activated cells is impaired as a direct consequence of a cholesterol deficit. This finding suggests that metabolic responses of cells to an initial activation event modulate later proximal signaling events.
Despite the diminished mTORC1 activity, we observed hyperactivation of Akt. This result is especially notable, given the decreased expression of IL-2Rβ , because this subunit directly leads to PI3K 36 . In agreement with this finding, under physiological stress, such as growth-factor limitations or reactive oxygen generation, Foxo1 can maintain high Akt and limit mTORC1 activity in mouse embryonic fibroblasts 37 . However, although these effects have been shown to decrease anabolic metabolism, we found that catabolic energy-consuming pathways are also limited.
Perhaps most importantly, we found that activation of Akt takes place via a noncanonical pathway, because it occurs independently of mTORC2 activity and is not blocked by deletion of Rictor. This finding was striking, because mTORC2 is essential for activation of Akt in T cells 38 . Several lines of evidence may account for this observation: altered signaling dynamics resulting from defective immunological synapse formation and CD3 expression; failure to recruit phosphatases to signaling platforms as a result of diminished PD-1 expression; decreased PTEN expression; and potentially loss of negative feedback from mTOR-S6K, a pathway that is well described in cancer cells 39 . Further studies will be needed to determine why interference with Foxo1 inactivation abolishes the requirement of mTORC2 activity for Akt phosphorylation on Ser473.
Our data on CD4 Cre mice suggest that maintaining one copy of Foxo1 AAA severely disrupts T reg cell ontogeny. This finding contrasts with those from a study in Foxp3
Cre mice, which has reported that maintaining one copy of Foxo1 AAA after T reg cell differentiation inhibits effector T reg function but does not interfere with naive T reg cell homeostasis 40 . Thus, although our data suggest a model of CD4 conventional T cell persistence in vivo that depends on oscillatory Foxo1 activity (to both allow growth-factor signals and support quiescence), after cell lineage commitment has been made, T reg cells appear to tolerate prolonged continuance of Foxo1 activity. These differences in how Foxo1 activity modulates conventional CD4
+ T cells and T reg cells may be exploitable in the context of T cell-based gene therapies or adoptive cellular therapy.
Collectively, our data show that maintained Foxo1 transcriptional activity alters T cell responsiveness and competitive fitness. Although in a noncompetitive environment, cell proliferation is enhanced, this effect occurs in conjunction with decreases in cell biomass and cholesterol content. In vivo, this response results in a failure to maintain homeostasis and in CD4 T cells marked by defective ribosome biogenesis and cholesterol biosynthesis. Together, these findings link the role of Foxos in controlling homing and migration with the coordination of growth and proliferation, and reveal how proper regulation of Foxos is critical to both maintaining tolerance and orchestrating immune responses.
Methods
Methods, including statements of data availability and any associated accession codes and references, are available at https://doi. org/10.1038/s41590-018-0157-4.
Mice. Rosa26-flox-STOP-FOXO1
AAA (Foxo1 AAA ) mice were generated and provided by M. Li 8 . CD4
Cre , CD45.1 + and Rag1 -/-mice were acquired from the Jackson laboratory. CD4
Cre-ERT2 mice were generated and provided by F. Gounari 41 . Rictor fl/fl mice have been described previously 42 . The experiments were not randomized; age-matched and, whenever possible, sex-matched littermate controls were used for all experiments. Unless otherwise noted, CD4
Cre Foxo1 AAA/+ mice were used at 4-8 weeks of age. Other mice were used at 4-12 weeks of age unless otherwise noted. No statistical methods were used to predetermine sample size, which was determined on the basis of animal availability and experience with analysis of the immune system and the development of early-onset lethal autoimmunity. Experimental analyses were not blinded. For Cre induction with CD4
Cre-ERT2 mice, 1 mg tamoxifen (Sigma-Aldrich) in corn oil was injected i.p. for five consecutive days and then either maintained for biweekly analysis of peripheral blood or analyzed 3 d after the last injection. All animals were cared for according to the guidelines of Massachusetts General Hospital and St. Jude's Children's Research Hospital, and the Institutional Animal Care and Use Committee approved all experimental protocols.
Bone marrow chimeras. 6-to 8-week-old recipient Rag1
-/-mice were sublethally irradiated (5 Gy) 16 h before retro-orbital transfer of 2 × 10 6 bone marrow cells from 4-week-old donors. Before transfer, bone marrow was depleted of CD3 RNA-seq analysis. Sequenced reads were aligned to the mm9 reference genome assembly, and gene counts were quantified with STAR (v2.5.1b). To identify genes differentially expressed between phenotypic groups, differential expression analysis was performed with the negative binomial generalized linear models implemented in the DESeq2 R package (Bioconductor). Gene-set enrichment analyses were performed with GSEAPreranked, in which genes were ranked according to their sign-corrected log 10 -adjusted P value and compared with the following MSigDB signature collections: curated hallmark gene sets, gene ontology biological processes and the c2 reactome 43, 44 . Functional analysis was performed with Database for Annotation, Visualization and Integrated Discovery (DAVID) bioinformatics resources 45 . Gene expression array data from wild-type and Scurfy CD4 T cells were analyzed with GEO2R from GEO GSE11775 to select genes with twofold expression change (P < 0.05) for gene ontology with DAVID. 
CD25
-populations were sorted, cultured at 37 °C and 5% CO 2 in complete RPMI 1640 medium and activated in vitro with plate-bound anti-CD3 (0.5 μ g/ml; 145-2C11, BioLegend) and soluble anti-CD28 (0.2 μ g/ml; 3751, BioLegend). To plate-bind anti-CD3, culture dishes were first coated with goat anti-hamster (7 μ g/ml, Vector Labs) in carbonate buffer (50 mM sodium carbonate and 50 mM sodium bicarbonate, pH 9.5). To measure cell proliferation and survival, sorted cells were labeled with CellTrace Violet (Invitrogen) before being cultured with plate-bound anti-CD3 and soluble anti-CD28; before flow cytometry, cells were stained with either 7AAAD (eBioscience) or Live/Dead Fixable Dead Cell stain. For IL-2 withdrawal assays, anti-IL-2 blocking antibody (JES6-1A12, BioLegend) was used. For inhibition of dynamin-and clathrin-mediated endocytosis, Dynasore (Sigma-Aldrich) was used. anti-CD132 (TUGm2), anti-CD45.1 (A20), anti-CD45.2 (104), anti-BrdU (Bu20a), anti-IFN-γ (XMG1.2), anti-granzyme B (GB11), anti-IL-4 (11B11), anti-MHC II I-Ab (AF6-120.1), anti-CD40 (3/23), anti-ICOS (7E.17G9), anti-CTLA-4 (UC10-4B9) and fluorophore-conjugated polyclonal anti-rabbit. Fluorophore-conjugated streptavidin was also from BioLegend. The following antibodies from eBioscience were used: anti-B7-1 (16-10A1), anti-Foxp3 (FJK-16s), anti-GL-7 (GL-7), anti-Fas (15A7) and biotin-conjugated anti-CXCR5 (SPRCL5). Anti-IL2 (JES6-5H4) was from BD Biosciences. For intracellular staining, a Foxp3 fix/perm kit (eBioscience) was used after surface staining. Intracellular staining of Myc was performed with anti-Myc (D84C12) from Cell Signaling. For staining of phosphorylated proteins, cells were fixed in 2% PFA and then permeabilized in 100% ice-cold MeOH. The following primary and secondary antibodies were stained in PBS containing 2% FBS: unconjugated anti-p-Akt Ser473 (D9E, Cell Signaling), fluorophoreconjugated polyclonal anti-rabbit (BioLegend) and fluorophore-conjugated antip-STAT5 Tyr694 (SRBCZX, eBioscience). All flow cytometry was analyzed with a Navios (Beckman Coulter) flow cytometer with standard filter sets and FlowJo software (TreeStar), except when a 561-nM laser was needed for RFP detection, for which an LSRII (Becton Dickson) was used.
In vivo BrdU labeling. 8-to 12-week-old mice that had received five daily, consecutive injections of tamoxifen 2 weeks earlier were injected with 1 mg BrdU in PBS every 12 h for three consecutive days. Cells that incorporated BrdU were detected with a BrdU Flow Kit (BD Biosciences) according to the manufacturer's instructions.
Retroviral transduction of T cell cultures.
The retroviral constructs MSCV-IRES-RFP (MIR and MIR-Myc) and MSCV-IRES-Thy1.1 (MIT and MITcaSTAT5b) were packaged in HEK 293 T cells maintained in DMEM supplemented with 10% FBS with the helper plasmids pHIT-60 and pHIT-123. To produce virus, HEK 293 T cells were transfected with constructs and helper plasmids with Lipofectamine 3000 reagent (Promega) according to the manufacturer's instructions. 12 h after transfection, the supernatant was removed, discarded and replaced with fresh DMEM; 12 h later, the medium was replaced with RPMI complete medium and collected and replaced every 12 h for the next 48 h. For retroviral transductions, sorted cells were activated for 24 h with plate-bound anti-CD3 and soluble anti-CD28. Cells were then treated with viral supernatant containing 4 μ g/ml polybrene and centrifuged at 500 g for 1 h. 24 h after transduction, medium containing viral supernatant was removed and replaced with fresh RPMI complete medium, and 48 h after transduction, cells were analyzed by flow cytometry.
Immunofluorescence imaging of Filipin III staining. Day 2 T cell cultures were adhered to Nunc glass-bottom cell culture dishes with Cell-Tak (BD Bioscience), fixed with 2% paraformaldhehyde and stained with Filipin III (45 min at room temperature, 50 μ g/ml final concentration). After being washed with PBS, stained cells were imaged with a Zeiss LSM710 confocal microscope and analyzed with ZEN software (Zeiss).
Immunofluorescence imaging of mTOR and lysosomes. Day 2 T cell cultures were adhered to Nunc glass-bottom cell culture dishes with Cell-Tak (BD Bioscience), then further incubated for an additional 2 h at 37 °C and 5% CO 2 in unsupplemented RPMI medium (Gibco) or RPMI medium supplemented with 11.1 mM glucose (Sigma), 10% FBS and RPMI 1640 amino acids solution (Sigma). Cell were fixed with 2% paraformaldhehyde, then permeabilized and blocked with 2% normal goat serum (Jackson ImmunoResearch) and 0.05% saponin (Sigma) in PBS at room temperature for 2 h. Primary-antibody staining for Lamp-1 (Developmental Studies Hybridoma Bank; 1D4B) and mTOR (Cell Signaling Technology; 7C10) was performed overnight at 4 °C and was followed by washing in perm/blocking buffer and secondary-antibody staining (Invitrogen; goat antirabbit IgG (H + L) Alexa Fluor 647 and goat anti-rat IgG (H + L) Alexa Fluor 594) for 1 h at room temperature in perm/blocking buffer. After being washed with PBS, stained cells were mounted in Fluoro-Gel II mounting medium containing DAPI (Electron Microcopy Sciences) and were imaged with a Zeiss LSM710 confocal microscope and analyzed with ZEN software (Zeiss).
Histology and immunohistochemistry.
For analysis of pathology and immune cell infiltration into nonlymphoid organs, tissue was fixed with 10% formalin, paraffin embedded, sectioned and stained with hematoxylin and eosin. For staining of IgG deposition in kidneys, 6-μ m-thick frozen sections of OCT-embedded kidneys were fixed with 3.2% formaldehyde (Polysciences), permeabilized in 90% methanol and incubated with blocking buffer (2% goat serum, 1% BSA, 0.1% cold fish skin gelatin, 0.1% saponin and 0.05% Tween-20 in 0.01 M PBS). Tissues were stained with Alexa 488-conjugated goat anti-mouse IgG (H + L) (Thermo Fisher). Fluorescence images were acquired with a Leica TCS SP5 II confocal microscope and Leica Acquisition Software. For autoantibody (ANA) staining, fixed HEp-2 ANA slides (MBL) were stained with PBS-diluted serum (1:50). Slides were washed and stained with either Alexa 488-conjugated goat anti-mouse IgG (H + L) or Alexa 568-conjugated goat anti-mouse IgM (Thermo Fisher) as detection antibodies. Fluorescence images were acquired with a Leica TCS SP5 II confocal microscope and Leica Acquisition Software.
Antibody quantification and ELISA. Immunoplate MaxiSorp plates (Thermo Fisher) were coated with 10 μ g/ml goat anti-mouse IgG (heavy and light chain specific; Southern Biotech) in PBS at 4 °C overnight. Plates were blocked with 1% BSA in PBS, washed and then incubated with diluted sera in PBS or standards. Plates were then incubated with 1:1,000 diluted alkaline phosphatase-conjugated IgM, IgG, or IgG1 (Southern Biotech). Secondary antibodies were detected by disodium p-nitrophenyl phosphate substrate (Sigma-Aldrich), and absorbance (OD) was read at 405 nm.
Blood and serum glucose analysis. Blood glucose was measured via saphenous vein blood collection, and levels were determined with an Ascensia Contour blood glucose meter and blood glucose monitoring strips (Bayer Healthcare). Red blood cell percentages were determined after heart-puncture blood collection. Blood was collected into microhematocrit tubes and spun for 120 s with a CritSpin StatSpin centrifuge (Iris Sample Processing). Separated serum and red blood cell percentages were determined with a Micro Hematocrit Capillary Tube Reader (StatSpin, Iris Sample Processing). Immunoblotting. Cells were lysed in RIPA buffer (150 mM NaCl, 1% NP-40, 0.5% sodium deoxycholate, 0.1% sodium dodecyl sulfate, 50 mM Tris, 1 mM EDTA and 1 mM EGTA), and immunoblotting was performed with standard procedures. Antibodies specific to the following proteins were obtained from Cell Signaling Technologies: Myc (D84C12), p-Akt Thr308 (C31E5E), p-Akt Ser473 (D9E), Akt (9272), p-S6 Ser235/236 (D57.2.2E), S6 (5G10), p-4E-BP1 Thr37/46 (236B4), p-mTOR Ser2448 (D9C2), p-PKCα /β Thr638/641 (9375), p-Ndrg1 Thr346 (D98G11), p-Jak1 Tyr1034/1035 (D7N4Z), p-Stat5 Tyr694 (D47E7), p-Pdk1 Ser241 (C49H2), Rictor (53 A2), LC-3A/B (D3U4C) and β -actin (D6A8). An Hif-1α -specific polyclonal antibody (10006421) was from Cayman Chemical, antiLamp-1 (1D4B) was from the Developmental Studies Hybridoma Bank, and anti-PTEN (6H2.1) was from Cascade Bioscience. Horseradish peroxidase-conjugated goat anti-rabbit IgG (Bio-Rad) was used as a secondary antibody. 5% milk in PBS with 0.1% Tween 2-0 was used as blocking buffer.
Metabolic assays. OCR and ECAR were measured with an XF96 extracellular flux analyzer (Seahorse Bioscience) according to the manufacturer's protocols. FACSsorted T cells from day 3 cultures were attached to culture plates with Cell-Tak (BD Bioscience) and were maintained in nonbuffered assay medium in a non-CO 2 incubator for 1 h before the assay. A Glycolysis Stress Test Kit (Seahorse Bioscience) was used to monitor ECAR in assay medium supplemented with 10 mM l-glutamine (HyClone). Three baseline recordings were made, and this was followed by sequential injection of glucose (10 mM), the mitochondrial/ATP synthase inhibitor oligomycin (3 μ M) and the glycolysis inhibitor 2-deoxy-dglucose (100 mM). Glycolytic capacity was defined as the difference between the ECAR after the injection of oligomycin and the basal ECAR. A Mito Stress Test Kit (Seahorse Bioscience) was used to assay the mitochondrial respiration rate with assay medium supplemented with 10 mM l-glutamine and 10 mM d-glucose (Sigma-Aldrich). Three baseline recordings were made, and this was followed by sequential injection of the ATP synthase inhibitor oligomycin (3 μ M), the mitochondrial uncoupler carbonyl cyanide-4-(trifluoromethoxy)phenyl-hydrazone (FCCP; 1 μ M) and the respiratory chain inhibitors antimycin A (1.5 μ M) and rotenone (3 μ M). Mitochondrial respiratory capacity was defined as the difference between the OCR after the injection of FCCP and the basal OCR. Glucose and glutamine consumption, and lactate and glutamate production, were measured in cell supernatants obtained at days 2 and 3 of cultures with a BioProfile Flex Analyzer (Nova Biomedical).
Supported lipid bilayer and total internal reflection fluorescence microscope imaging. SLBs were formed as previously described 23 . In brief, glass coverslips were cleaned with piranha solution (30% H 2 O 2 and 70% H 2 SO 4 ), rinsed extensively, dried, negatively charged through plasma cleaning, and assembled with a sixchannel sticky-Slide VI 0.4 (Ibidi). SLBs were formed by filling each channel with a suspension of small unilamellar vesicles composed of 1,2-dioleoyl-sn-glycero-3-[N-(5-amino-1-carboxypentyp) succinyl] (12.5% mol) and 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-cap biotinyl (0.05% mol) in 1,2-dioleoyl-sn-glycero-3-phosphocholine at a total lipid concentration of 0.4 mM (Avanti Polar Lipids). SLBs were blocked with 5% casein (Sigma), 10% human serum albumin (Calbiochem), 100 µ M NiSO 4 ) titrated to obtain indicated densities after a 20-min incubation. Mouse CD4 T cells were sorted after 3 d of activation by plate bound anti-CD3/ CD28 in GFP + (ca-Foxo1) and GFP (wild type) populations; rested for at least 6 h at 37 °C in 25 U/ml rhIL-2 (Immunotools); and incubated for 10 min. at 37 °C on prewarmed SLBs. T cells were fixed with 4% paraformaldehyde in 60 mM PIPES, 25 mM HEPES, 10 mM EGTA, 4 mM MgCl 2 (PHEM buffer), pH 7, extensively washed and subsequently imaged on an Olympus IX83 inverted microscope equipped with Olympus UApON 150× , 1.45-NA objective, 405-, 568-, 647-nm argon laser, and an Evolve delta EMCDD camera. Successful immunological synapse formation was blindly scored as the percentage of SLB-bound T cells with a cSMAC defined as location with dense 2C11 and exclusion of ICAM-1. IRM was used to determine the T cell-SLB interaction surface area. This area was used as a mask in Fiji 46 to determine the recruitment of TCR and LFA-1, as determined by the integrated densities of 2C11 and ICAM-1.
Cholesterol administration before imaging. Mouse CD4 T cells were incubated with culture medium (RPMI 1640, 5% FBS, pen/strep and l-glutamine; all from Gibco) supplemented with 10 µ g/ml MßCD-coated cholesterol at 37 °C for 15 min. The cells were washed three times with 37 °C PBS (Gibco), resuspended in culture medium and finally incubated on SLBs.
Filipin III staining for immunological synapse imaging. Filipin III (Sigma) was dissolved in ethanol to a final concentration of 5 mg/ml. Cells were fixed with 4% paraformaldehyde in PHEM buffer, pH 7, extensively washed and stained with 50 µ g/ml Filipin III for 30 min at 4 °C. After three washes with 4 °C PBS, cells were placed in glass-bottom eight-well µ -well slides (Ibidi) and imaged on an Olympus confocal microscope. The integrated density of Filipin was determined in Fiji.
Statistical analysis. All statistical analyses were performed in Prism software (GraphPad). Data were analyzed with two-tailed, unpaired Student's t tests to determine whether two means were significantly different, and P < 0.05 was considered significant, unless otherwise indicated. The variance was similar between groups being statistically compared. Life Sciences Reporting Summary Nature Research wishes to improve the reproducibility of the work that we publish. This form is intended for publication with all accepted life science papers and provides structure for consistency and transparency in reporting. Every life science submission will use this form; some list items might not apply to an individual manuscript, but all fields must be completed for clarity.
For further information on the points included in this form, see Reporting Life Sciences Research. For further information on Nature Research policies, including our data availability policy, see Authors & Referees and the Editorial Policy Checklist.
Experimental design 1. Sample size
Describe how sample size was determined. Sample size was determined empirically, at least two independent experiments were conducted. No statistical methods were used to predetermine sample size; this was determined based on animal availability and experience with analysis of the immune system and the development of early-onset lethal autoimmunity.
Data exclusions
Describe any data exclusions. No data were excluded from the analyses.
Replication
Describe whether the experimental findings were reliably reproduced.
The experimental findings were reliable reproduced.
Randomization
Describe how samples/organisms/participants were allocated into experimental groups.
The experiments were not randomized; age-matched and whenever possible sexmatched littermate controls were used for all experiments.
Blinding
Describe whether the investigators were blinded to group allocation during data collection and/or analysis.
No blinding was used in this study. Analysis was performed by software independently of biased intervention. Internal negative and positive controls were used to obtain unbiased data where applicable (for example, gating in flow cytometry).
Note: all studies involving animals and/or human research participants must disclose whether blinding and randomization were used.
Statistical parameters
For all figures and tables that use statistical methods, confirm that the following items are present in relevant figure legends (or in the Methods section if additional space is needed).
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement (animals, litters, cultures, etc.)
A description of how samples were collected, noting whether measurements were taken from distinct samples or whether the same sample was measured repeatedly A statement indicating how many times each experiment was replicated
The statistical test(s) used and whether they are one-or two-sided (note: only common tests should be described solely by name; more complex techniques should be described in the Methods section)
A description of any assumptions or corrections, such as an adjustment for multiple comparisons
The test results (e.g. P values) given as exact values whenever possible and with confidence intervals noted A clear description of statistics including central tendency (e.g. median, mean) and variation (e.g. standard deviation, interquartile range)
Clearly defined error bars
See the web collection on statistics for biologists for further resources and guidance.
